Show results for
Refine by
Testing Services Targeting To Preclinical Studies Equipment Supplied In Taiwan
2 equipment items found
Manufactured by:BRIM Biotechnology, Inc. based inTaipei City, TAIWAN
BRM423 is targeted to treat severe corneal damage. BRM423 is novel synthetic peptide derived from human Pigment Epithelium-Derived Factor (PEDF). Its active ingredient is the same as the BRM421 for Dry Eye Syndrome, but it is targeted to treat severe corneal damage. Based on BRIM’s proprietary PDSP technology platform, BRIM intends to rapidly advance development of this novel treatment for ...
Manufactured by:BRIM Biotechnology, Inc. based inTaipei City, TAIWAN
Neurotrophic Keratitis is a rare, degenerative disease characterised by corneal sensitivity reduction, spontaneous epithelium breakdown, and impairment of corneal healing. Currently, there is only one drug, Oxervate (Cenegermin), approved by the US FDA and EMA in 2018. Eye health is crucial to quality of life and BRIM is advancing new therapeutics to support patients affected by Neurotrophic ...